Invanz and Rotator cuff syndrome - a phase IV clinical study of FDA data

Summary:

Rotator cuff syndrome is reported as a side effect among people who take Invanz (ertapenem sodium), especially for people who are female, 50-59 old, also take Zometa, and have Osteoporosis.

The phase IV clinical study analyzes which people have Rotator cuff syndrome when taking Invanz. It is created by eHealthMe based on reports of 3,924 people who have side effects when taking Invanz from the FDA, and is updated regularly.

What is Invanz?

Invanz has active ingredients of ertapenem sodium. It is often used in urinary tract infection. eHealthMe is studying from 3,961 Invanz users. Check the latest studies of Invanz.

What is Rotator cuff syndrome?

Rotator cuff syndrome (a spectrum of conditions affecting the rotator cuff tendons of the shoulder) is found to be associated with 1,088 drugs and 1,121 conditions by eHealthMe. Check the latest studies of Rotator cuff syndrome.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 29, 2026

3,924 people reported to have side effects when taking Invanz.
Among them, 40 people (1.02%) have Rotator cuff syndrome.

Could Invanz cause Rotator cuff syndrome?

Among these 40 people:

What is the gender of people who have Rotator cuff syndrome when taking Invanz? *

female: 70 %
male: 30 %

What is the age of people who have Rotator cuff syndrome when taking Invanz? *

What are other drugs people take besides Invanz? *

What are other side effects people have besides Rotator cuff syndrome? *

Spinal Osteoarthritis (joint cartilage loss in spine): 40 people, 100.00%
Cellulitis (infection under the skin): 40 people, 100.00%
Exostosis (formation of new bone on the surface of a bone): 40 people, 100.00%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 40 people, 100.00%
Sinusitis (inflammation of sinus): 40 people, 100.00%
Wound Infection Staphylococcal: 39 people, 97.50%
Bone Disorder: 39 people, 97.50%
Vasculitis (inflammation of a blood vessel or blood vessels): 39 people, 97.50%
Bone Fragmentation: 39 people, 97.50%
Dental Caries: 39 people, 97.50%

What are the existing conditions these people have? *

Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 27 people, 67.50%
Osteoporosis (bones weak and more likely to break): 27 people, 67.50%
Trismus (reduced opening of the jaws): 12 people, 30.00%
Multiple Myeloma (cancer of the plasma cells): 12 people, 30.00%
Thrombocytopenia (decrease of platelets in blood): 11 people, 27.50%
Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 1 person, 2.50%
Acne (skin problems that cause pimples): 1 person, 2.50%

* Approximation only. Some reports may have incomplete information.

Do you take Invanz and have Rotator cuff syndrome?

- Check whether Rotator cuff syndrome is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Invanz:

Invanz (3,961 reports)

Browse all side effects of Invanz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rotator cuff syndrome:

Rotator cuff syndrome (1,088 drugs)

Browse all the conditions that are associated with Rotator cuff syndrome:

Rotator cuff syndrome (1,121 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ertapenem sodium (the active ingredients of Invanz) and Invanz (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.